Matthias Guckenberger
@Mat_Guc
Radiation Oncologist at University Hospital Zurich @Unispital_USZ | Professor at University of Zurich @UZH_ch | @ESTRO_RT President
❓ Role of SBRT-only in hormone-sensitive oligometastatic prostate cancer ❓ Value of 6-months ADT added to SBRT ❓ Appropriate endpoints Virtual Grand Rounds in Radiation Oncology usz.ch/en/events/virt… Proudly presenting: @BarbaraJereczek Wed April 2nd 17:00 – 17:30 CET 👇
Great collaboration between MOMENTUM and Oligocare registries, presenting the preliminary outcomes (of 15 institutions) regarding liver SBRT using MRI or CT guided approach during #ESTRO2025 !
🎥 Exclusive interview this morning at #ESTRO25: We spoke with ESTRO President Prof Matthias Guckenberger about the congress highlights, this year’s theme of partnership, and the future of radiation oncology. Don’t miss his insights ⬇️ #Radiotherapy #CancerResearch @Mat_Guc
Greetings from #ESTRO25 and a wam welcome to #APCCC26 in Lugano 🇨🇭 @Silke_Gillessen @BarbaraJereczek @piet_ost @ZilliThomas @GiulioFrancoli1 @Mat_Guc @VedangMurthy @OncoAlert 🚨
SBRT + 💊 in oligomets: 🧍♂️2294 pts | 🫁, breast, prostate, colorectal ⚠️Grade 3+ AEs: 1.5% ✅ SBRT Safe with systemic tx! #SBRT #OligoCare #ESTRO25 @EORTC @ESTRO_RT @CiroFranzese1
Outstanding #ESTRO25 plenary talk from Uffer Pascal, an entrepreneur with stage 4 #lungcancer “What if radiation oncology was a start up” Highlights the 5’s: Collaborate Communicate Learn from every Customer Cost Efficiency Culture
📢 🚨#lungcancer peeps. Please consider Prof Andrea Bezjak from @UofT for your next IASLC president! A very deserving candidate and a great representative for #radonc!!! @ldawsonmd #lcsm
🎉We’re excited to announce that the first patient has been randomised in the SPRINT study! The patient was enrolled at Inselspital in Bern, under the supervision of PI Professor Hossein Hemmatazad. 👉 project.eortc.org/e2-radiate/202… #E2RADIatE #OligoCare @piet_ost @Mat_Guc
🏅 Interview with Dirk Verellen, recipient of the Emmanuel van der Schueren Award at #ESTRO25: Don’t miss his award lecture in Vienna! 📆 Saturday 3 May | 14:15 - 14:40 CEST | Plenary Hall 👉 Full interview here: bit.ly/4ifJd75 #Radonc #OncologyInnovation #ESTROAwards
SANO trial: non-surgical approach & organ preservation in pts esophageal cancer and complete clinical response after neoadjuvant RCT Virtual Grand Rounds in Radiation Oncology usz.ch/en/events/virt… Wednesday May 7th 17:00 – 17:30 - Safe the date ! Berend van der Wilk
This Wednesday 👇
❓ Role of SBRT-only in hormone-sensitive oligometastatic prostate cancer ❓ Value of 6-months ADT added to SBRT ❓ Appropriate endpoints Virtual Grand Rounds in Radiation Oncology usz.ch/en/events/virt… Proudly presenting: @BarbaraJereczek Wed April 2nd 17:00 – 17:30 CET 👇
#ELCC25 in Paris has started with @ESTRO_RT being a partner of the meeting Such multidisciplinary meetings are THE place to learn from our neighboring disciplines & teach them about the value of Radiation Oncology Tomorrow: borderline resectable stage III NSCLC, hot topic
Health Business International conference in Paris Change of perspective on health care, financial models and opportunities for collaboration between academic public, and private sectors
Innovation in RadOnc is strong HOWEVER, regulatory processes for clinical trials have become prohibitively complex & costly Innovative & collaborative research as SPRINT using TwiCs methodology by the @ESTRO_RT & @EORTC are testing new ways to generate evidence
🎉 We are excited to announce that the first two centres have been activated for the SPRINT clinical trial, the first pan-European Trial within Cohorts (TwiCs), leveraging real-world data from the #E2RADIatE #OligoCare cohort. Find out more: project.eortc.org/e2-radiate/202… #SPRINTtrial
@EORTC launches first European TwiCs within OligoCare randomising single vs multifraction SBRT for oligomets! @Mat_Guc
🎉 We are excited to announce that the first two centres have been activated for the SPRINT clinical trial, the first pan-European Trial within Cohorts (TwiCs), leveraging real-world data from the #E2RADIatE #OligoCare cohort. Find out more: project.eortc.org/e2-radiate/202… #SPRINTtrial
Multidisciplinarity is key in diagnosis and treatment of thoracic malignancies #BTOG25 is leading the way, congrats to @DrSanjayPopat and all UK colleagues !
🚨 ESTRO Board Elections – Reminder! Voting opens soon (20 March–20 April)! If you wish to vote for the new Clinical and Physics representatives, you must be an ESTRO member in both 2024 & 2025. ⌛ Renew your 2025 membership by 10 March to be eligible to vote, only 1 week left!
On my way CU tomorrow 🙋♂️
En route to #BTOG25? The team are ready! Looking forward to seeing you there. Do say “hello” when you catch me! It will be an awesome meeting!@BTOGORG